Skip to main content
Contact Us
Subscribe
e-Edition
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Site search
Search
Menu
Subscribe
Home
Contact Us
Terms of Use
Privacy Policy
Home Delivery
Subscribe
Submission Forms
Place an Ad
Weather
News
Sports
Entertainment
Calendar
Obituaries
Classifieds
Place an ad
e-Edition
Best of 2023
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Guardant Health Inc
(NQ:
GH
)
27.95
-0.59 (-2.07%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 16, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Guardant Health Inc
< Previous
1
2
3
4
5
6
7
Next >
This Nasdaq Healthcare Stock's Pain Is Its Rival's Gain
December 16, 2022
The broader market lost more ground on Friday.
Via
The Motley Fool
AVYA Stock Alert: Is Avaya Holdings Nearing Bankruptcy?
December 16, 2022
Avaya (AVYA) stock is falling hard on Friday following recent reports that the company is closing in on a bankruptcy filing.
Via
InvestorPlace
Why Is Exact Sciences (EXAS) Stock Up 23% Today?
December 16, 2022
Exact Sciences (EXAS) stock is on the rise Friday following news that Guardant Health's (GH) clinical trial didn't go as well as expected.
Via
InvestorPlace
Guardant Health (GH) Stock Sinks on Disappointing Blood Test Results
December 16, 2022
Guardant spent more money than it took in while hoping to become a leader in cancer diagnosis, but accuracy remains a problem.
Via
InvestorPlace
12 Health Care Stocks Moving In Friday's Pre-Market Session
December 16, 2022
Via
Benzinga
Why Adobe Shares Are Trading Higher; Here Are 31 Stocks Moving Premarket
December 16, 2022
Gainers Minim, Inc. (NASDAQ: MINM) shares rose 66.5% to $0.2903 in pre-market trading after gaining over 10% on Thursday. Minim, last month, reported worse-than-expected results.
Via
Benzinga
8 Analysts Have This to Say About Guardant Health
November 18, 2022
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday
December 16, 2022
We're starting off the final trading day this week with a look at the biggest pre-market stock movers to watch for Friday!
Via
InvestorPlace
Guardant Health, Novavax And Some Other Big Stocks Moving Lower In Today's Pre-Market Session
December 16, 2022
U.S. stock futures traded lower this morning. Here are some big stocks recording losses in today’s pre-market trading session.
Via
Benzinga
Tesla, Apple, Novavax, Adobe, Guardant Health: Why These 5 Stocks Are Drawing Investors' Attention Today
December 15, 2022
Major Wall Street indices closed over 2% lower on Thursday after U.S. retail sales saw their steepest drop in close to a year last month, suggesting consumers are reining in spending around the...
Via
Benzinga
Exact Sciences Rockets As Guardant's Blood Test Pales Vs. Cologuard
December 15, 2022
Exact Sciences' Cologuard has a higher specificity than Guardant's blood test.
Via
Investor's Business Daily
Expert Ratings for Guardant Health
November 18, 2022
Via
Benzinga
Stephens Starts Coverage On This Precision Oncology Company With 66% Upside
October 06, 2022
Via
Benzinga
Analyst Ratings for Guardant Health
October 06, 2022
Analysts have provided the following ratings for Guardant Health (NASDAQ:GH) within the last quarter:
Via
Benzinga
After-Hours Action: What's Going On With Guardant Health, Exact Sciences Shares?
December 15, 2022
Guardant Health Inc (NASDAQ: GH) and Exact Sciences Corp (NASDAQ: EXAS) shares are moving in different directions in Thursday's after-hours session. Here's a look at what's going on.
Via
Benzinga
12 Health Care Stocks Moving In Thursday's After-Market Session
December 15, 2022
Via
Benzinga
2 Top Healthcare Stocks to Buy for the Long Haul
December 09, 2022
These two companies are just getting started.
Via
The Motley Fool
10 Health Care Stocks Whale Activity In Today's Session
November 29, 2022
This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity...
Via
Benzinga
Cathie Wood Increases Stake In 4 Stocks By Over 1,000% - Plus 4 New Holdings For Ark
November 22, 2022
Cathie Wood’s ARK Innovation ETF (ARCA: ARKK) is down roughly 63% year-to-date, compared to the NASDAQ which is down at least 29% year-to-date and the S&P 500 down over 16% year-to-date.
Via
Benzinga
Where Guardant Health Stands With Analysts
November 01, 2022
Over the past 3 months, 6 analysts have published their opinion on Guardant Health (NASDAQ:GH) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a...
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For November 1, 2022
November 01, 2022
Upgrades
Via
Benzinga
Why Guardant Health Stock Fell 5.5% Today
October 19, 2022
Is Guardant Health as obvious a bargain as this analyst makes it out to be?
Via
The Motley Fool
Benzinga's Top Ratings Upgrades, Downgrades For October 19, 2022
October 19, 2022
Upgrades
Via
Benzinga
Why Guardant Health Topped the Market on Thursday
October 06, 2022
Add another name to the list of the cancer-diagnostic company's bulls.
Via
The Motley Fool
Benzinga's Top Ratings Upgrades, Downgrades For October 6, 2022
October 06, 2022
Upgrades
Via
Benzinga
Netflix, Biogen And Other Big Gainers From Wednesday
September 29, 2022
U.S. stocks closed higher with the Dow Jones surging more than 500 points on Wednesday. Here is the list of some big stocks recording gains in the previous session.
Via
Benzinga
FDA To Review Smaller Number Of Emergency Use Requests For COVID-19 Tests
September 27, 2022
Via
Benzinga
COVID-19 Complacency Pushes Identification Of New Variants To Back Seat, WHO Warns
September 23, 2022
The World Health Organization (WHO) warned that it struggles to identify and
Via
Benzinga
US Department Of Health, Defense To Inject $1B To Boost Domestic Biomanufacturing
September 14, 2022
Via
Benzinga
Biden Administration Pushes 'Cancer Moonshot' Initiative: Report
September 13, 2022
President Joe Biden channeled John F. Kennedy on the 60th anniversary of the former President's moonshot speech, highlighting the Biden administration's efforts to "end cancer as we know it." The...
Via
Benzinga
< Previous
1
2
3
4
5
6
7
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.